Press release from Companies: DanCann Pharma A/S Completes Issuance of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

Press release from Companies: DanCann Pharma A/S Successfully Receives First Tranche from the 10-Year Financing Loan-Agreement with 12-months Conversion Option and Warrants with Nordic Growth Opportunities 2

Press release from Companies: DanCann Pharma A/S: MINUTES OF EXTRAORDINARY GENERAL MEETING

Press release from Companies: DanCann Pharma A/S: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

Press release from Companies: DanCann Pharma A/S Secures 10-Year Financing Loan-Agreement with 12-months Conversion Option and Warrants

Press release from Companies: DanCann Pharma receives approximately DKK 5.6 million from the exercise of series TO 2 together with a directed issue to the underwriters

Press release from Companies: DanCann Pharma A/S' Pre-Validation Batches Meets European Standards, paving the Path for Final Product Approval

Press release from Companies: DanCann Pharma A/S publishes Q1-2023 report

Press release from Companies: DanCann Pharma A/S: MINUTES OF ANNUAL GENERAL MEETING

Press release from Companies: DanCann Pharma A/S has secured 71 percent of the TO 2’s

Press release from Companies: DanCann Pharma A/S has successfully completed pre-validation batches and expects final approval from the Danish Medicines Agency by the end of summer

Press release from Companies: DanCann Pharma A/S in advanced talks with new investor of additional DKK 12 million for topping up the outcome of the TO 2’s